Recursion Pharmaceuticals (RXRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

6.640
+0.240+3.75%

Close Nov 4 16:00 ET

6.660
+0.020+0.30%

Post 20:01 ET

1.94BMarket Cap-4000P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cathie Wood's ARK Investment Buys 106K Shares of Recursion Pharmaceuticals Today
TipRanks20:25 ET
Peering Into Recursion Pharmaceuticals's Recent Short Interest
BenzingaNov 4 08:46 ET
10 Health Care Stocks Moving In Monday's Pre-Market Session
BenzingaNov 4 07:29 ET
Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
Yahoo FinanceNov 2 09:45 ET
Earnings Preview: RXRX to Report Financial Results Post-market on November 06
Moomoo NewsOct 31 21:00 ET
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
BenzingaOct 31 15:23 ET

Comments

Sean Parker

Nov 2 15:04

earnings to watch

$Recursion Pharmaceuticals (RXRX.US)$
This company has so much potential. look into it before asking me why. Google

Meltyy

Oct 11 01:22

🚨 M&A Update! 🚨

Keep an eye on these recently announced & closed M&As: 👀
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔

Big bull Salvekar

Oct 10 02:43

This field is the future 🔥🔥

$Recursion Pharmaceuticals (RXRX.US)$
soon all bioinformatics stocks will be in double digit
Google Deepmind founder shares Nobel prize in chemistry for AI that unlocks the shape of proteins